MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lexaria Bioscience Corp. - Warrant (NQ:LEXXW)

0.0012 UNCHANGED
Last Price Updated: 3:34 PM EST, Jan 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0012
Bid (Size) 0.0010 (100,000)
Ask (Size) 0.0051 (9,800)
Prev. Close 0.0012
Today's Range 0.0012 - 0.0012
52wk Range 0.0012 - 0.4384
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Lexaria Announces Positive Final Results From Human Pilot Study #5
Via ACCESS Newswire
News headline image
Lexaria Awarded Six Additional Patents
Via ACCESS Newswire

Performance

YTD
-86.8%
-86.8%
1 Month
N/A
N/A
3 Month
-98.2%
-98.2%
6 Month
-98.7%
-98.7%
1 Year
-99.5%
-99.5%

More News

Read More
News headline image
Lexaria Releases Annual Letter from the CEO
Via ACCESS Newswire
News headline image
Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4
Via ACCESS Newswire
News headline image
Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4
Via ACCESS Newswire
News headline image
Lexaria Attending BIO International Convention
Via ACCESS Newswire
News headline image
Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Via ACCESS Newswire
News headline image
Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Via ACCESS Newswire
News headline image
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended
Via ACCESS Newswire
News headline image
Lexaria Bioscience Corp. Provides Strategic Update
Via ACCESS Newswire
News headline image
Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Via ACCESS Newswire
News headline image
Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Via ACCESS Newswire
News headline image
Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain
Via ACCESS Newswire
News headline image
Lexaria Attending the 27th Annual H.C. Wainwright Global Investment Conference
Via ACCESS Newswire
News headline image
Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone
Via ACCESS Newswire
News headline image
GLP-1 "Arms Race" Broadens to Include Dozens of Companies
Via ACCESS Newswire
News headline image
Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study
Via ACCESS Newswire
News headline image
Lexaria's DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry
Via ACCESS Newswire
News headline image
Lexaria Reaches Patent Milestone - 50 Patents Now Granted Worldwide
Via ACCESS Newswire
News headline image
Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule
Via ACCESS Newswire
News headline image
Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company
Via ACCESS Newswire
News headline image
Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock
Via ACCESS Newswire
News headline image
Lexaria Announces $2 Million Registered Direct Offering of Common Stock
Via ACCESS Newswire
News headline image
Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience’s Technology
Via ACCESS Newswire
News headline image
Lexaria Updates its Ongoing Human Study GLP-1-H24-4
Via ACCESS Newswire

Frequently Asked Questions

Is Lexaria Bioscience Corp. - Warrant publicly traded?
Yes, Lexaria Bioscience Corp. - Warrant is publicly traded.
What exchange does Lexaria Bioscience Corp. - Warrant trade on?
Lexaria Bioscience Corp. - Warrant trades on the Nasdaq Stock Market
What is the ticker symbol for Lexaria Bioscience Corp. - Warrant?
The ticker symbol for Lexaria Bioscience Corp. - Warrant is LEXXW on the Nasdaq Stock Market
What is the current price of Lexaria Bioscience Corp. - Warrant?
The current price of Lexaria Bioscience Corp. - Warrant is 0.0012
When was Lexaria Bioscience Corp. - Warrant last traded?
The last trade of Lexaria Bioscience Corp. - Warrant was at 01/13/26 03:34 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story